Los Angeles Capital Management’s PRA Health Sciences, Inc. PRAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-8,166
Closed -$1.25M 1737
2021
Q1
$1.25M Sell
8,166
-630
-7% -$85.6K 0.01% 795
2020
Q4
$1.1M Hold
8,796
﹤0.01% 897
2020
Q3
$892K Buy
8,796
+1,045
+13% +$107K ﹤0.01% 864
2020
Q2
$754K Buy
7,751
+913
+13% +$85K ﹤0.01% 958
2020
Q1
$568K Sell
6,838
-6,311
-48% -$615K ﹤0.01% 865
2019
Q4
$1.46M Buy
13,149
+554
+4% +$57K 0.01% 724
2019
Q3
$1.25M Sell
12,595
-3,386
-21% -$336K 0.01% 752
2019
Q2
$1.58M Sell
15,981
-5,390
-25% -$514K 0.01% 703
2019
Q1
$2.36M Buy
21,371
+1,039
+5% +$109K 0.01% 612
2018
Q4
$1.87M Sell
20,332
-51,344
-72% -$5.2M 0.01% 573
2018
Q3
$7.9M Buy
71,676
+61,455
+601% +$6.4M 0.04% 377
2018
Q2
$954K Sell
10,221
-15,647
-60% -$1.35M 0.01% 916
2018
Q1
$2.15M Buy
25,868
+125
+0.5% +$11.1K 0.01% 618
2017
Q4
$2.34M Sell
25,743
-6,832
-21% -$568K 0.01% 623
2017
Q3
$2.48M Buy
32,575
+24,070
+283% +$1.82M 0.01% 566
2017
Q2
$638K Buy
8,505
+160
+2% +$11.1K ﹤0.01% 876
2017
Q1
$544K Buy
+8,345
New +$492K ﹤0.01% 870

Other funds holding PRAH

Los Angeles Capital Management's PRAH Position: Q2 2021 in Review

Los Angeles Capital Management sold out of PRA Health Sciences, Inc. (PRAH) in Q2 2021, closing a stake of 8,166 shares — an estimated $1.25M sold.

Los Angeles Capital Management first reported a position in PRAH in Q1 2017 and held it in 17 quarters. The position peaked at $7.9M in Q3 2018. 317 funds tracked by Wall St. Rank hold PRAH as of Q2 2021.

  • Los Angeles Capital Management reported no remaining PRA Health Sciences, Inc. position as of Q2 2021 after selling out during the quarter.
  • Los Angeles Capital Management sold 8,166 PRA Health Sciences, Inc. shares in Q2 2021, an estimated $1.25M.
  • Los Angeles Capital Management first reported a position in PRA Health Sciences, Inc. in Q1 2017 and held it in 17 quarters.
  • Los Angeles Capital Management's PRA Health Sciences, Inc. position peaked at $7.9M in Q3 2018.
  • 317 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q2 2021.

Based on Los Angeles Capital Management's 13F filing for Q2 2021, filed 5 Aug 2021.